Obsidian Therapeutics, Inc.
18.68USD
-0.0500 (-0.27%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 |
|---|---|
| Revenue | — |
| Cost of Revenue | — |
| Gross Profit | — |
| Operating Income | — |
| Net Income | 0 |
| EPS (Diluted) | — |
Source: SEC filings (EDGAR)